← Human Trials & Peer-Reviewed Studies
Multimedia tablet or paper handout to supplement counseling during preterm birth hospitalization: a randomized controlled trial.
Plain-language guide to PMID 36708966 (2023): randomized controlled trial of Copper (Supplement).
Key Facts
- PMID
- 36708966
- Journal
- American journal of obstetrics & gynecology MFM
- Year
- 2023
- Study type
- Randomized Controlled Trial
- Authors
- Rau NM et al. (8 authors)
- DOI
- 10.1016/j.ajogmf.2023.100875
- Registered trial
- NCT03225885
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Copper (Supplement), published as a randomized controlled trial.
Parents of premature infants engage in shared decision-making regarding the care of their infant.
The process of prenatal counseling typically involves a verbal conversation with a neonatal provider during hospitalization.
Who Took Part
By PubMed's age tags, the people studied were infants, children, teenagers and adults, women only.
Exclusion criteria were known fetal or chromosomal anomaly and delivery before study completion.
Preintervention assessment included demographics and State-Trait Anxiety Inventory, and postintervention assessment included the Parent Knowledge of Premature Birth Questionnaire and State-Trait Anxiety Inventory.
How the Study Was Run
In design terms this was a randomized study.
The participants were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.
This was a randomized controlled trial including English-speaking pregnant people aged ≥18 years and hospitalized at 22 to 33 weeks' gestation for preterm birth.
Pregnant people received either a multimedia tablet or a paper handout before verbal clinician counseling.
Continuous variables were analyzed by t-test and categorical variables by Fisher exact test.
What Was Measured
PubMed files the paper under topics including United States, Premature Birth, Multimedia, Infant, Premature, Gestational Age and Counseling.
Author keywords: communication, decision support, decision-making, maternal-fetal medicine, neonatology and patient education.
What This Means in Plain Language
The paper is a randomized study of Copper (Supplement).
Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2023 (American journal of obstetrics & gynecology MFM), a journal based in United States.
More context: the Copper (Supplement) compound page, all human trials.
Our Notes on the Compound
Copper (Supplement): The active site of cytochrome c oxidase is described as containing copper ions that are essential for electron transfer.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.